Contact information
Lisa Holland
PhD
Researcher, Vascular Overviews Group
Lisa Holland completed an undergraduate degree in Biochemistry with Microbiology at Lancaster University and a PhD in Molecular Microbiology at the University of Nottingham. After spending time as a secondary school teacher Lisa joined CTSU in 2006 where she is a member of the Vascular Overviews Group.
Lisa has worked on the meta-analyses of clinical trials of statins (Cholesterol Treatment Trialists Collaboration), of non-steroidal anti-inflammatory drugs (Coxib and NSAID Trialists Collaboration), and is currently working on a meta-analysis of clinical trials of antiplatelet drugs.
Recent publications
-
Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis.
Journal article
Marthi A. et al, (2018), J Am Soc Nephrol
-
Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials.
Journal article
Scally B. et al, (2018), Lancet Gastroenterol Hepatol, 3, 231 - 241
-
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials.
Journal article
Cholesterol Treatment Trialists' (CTT) Collaboration None. et al, (2015), Lancet, 385, 1397 - 1405
-
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials.
Journal article
Coxib and traditional NSAID Trialists' (CNT) Collaboration None. et al, (2013), Lancet, 382, 769 - 779
-
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.
Journal article
Cholesterol Treatment Trialists’ (CTT) Collaboration None. et al, (2010), Lancet, 376, 1670 - 1681